Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
South Korean researchers found no difference in the rates of liver cancer, liver transplant or death based on the treatment used.
Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.
The change targets LGBT people and those with chronic conditions. Here’s how patient groups and Lambda Legal respond.
Help find the “missing millions” who don’t know they’re living with viral hepatitis.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
An analysis conducted in Taiwan analyzed health outcomes over more than a decade.
Researchers reached this conclusion after reviewing data on more than 30,000 people.
European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.
Even positive breaking news looks different to people who know the reality of a hard-to-treat cancer.
Study in China sees an association with several cancer types, especially gastrointestinal malignancies.
Four things you should know to be #HepAware.
The drug is still associated with a lower liver cancer rate than Baraclude.
A quick overview of our reporting on the 53rd International Liver Congress in Vienna
Fecal microbiota transplantation can help reverse brain impairment in people with liver failure.
Tenofovir was associated with a lower risk of hepatocellular carcinoma, but this might be related to other factors as well.
People who took Viread were about two thirds less likely to develop HCC, but this could be related to other factors as well.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.